Correlation Between Biomarin Pharmaceutical and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Biomarin Pharmaceutical and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomarin Pharmaceutical and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomarin Pharmaceutical and Terns Pharmaceuticals, you can compare the effects of market volatilities on Biomarin Pharmaceutical and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomarin Pharmaceutical with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomarin Pharmaceutical and Terns Pharmaceuticals.
Diversification Opportunities for Biomarin Pharmaceutical and Terns Pharmaceuticals
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Biomarin and Terns is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Biomarin Pharmaceutical and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Biomarin Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomarin Pharmaceutical are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Biomarin Pharmaceutical i.e., Biomarin Pharmaceutical and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Biomarin Pharmaceutical and Terns Pharmaceuticals
Given the investment horizon of 90 days Biomarin Pharmaceutical is expected to generate 0.34 times more return on investment than Terns Pharmaceuticals. However, Biomarin Pharmaceutical is 2.97 times less risky than Terns Pharmaceuticals. It trades about -0.06 of its potential returns per unit of risk. Terns Pharmaceuticals is currently generating about -0.08 per unit of risk. If you would invest 6,668 in Biomarin Pharmaceutical on August 31, 2024 and sell it today you would lose (126.00) from holding Biomarin Pharmaceutical or give up 1.89% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biomarin Pharmaceutical vs. Terns Pharmaceuticals
Performance |
| Timeline |
| Biomarin Pharmaceutical |
| Terns Pharmaceuticals |
Biomarin Pharmaceutical and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biomarin Pharmaceutical and Terns Pharmaceuticals
The main advantage of trading using opposite Biomarin Pharmaceutical and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomarin Pharmaceutical position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
| Terns Pharmaceuticals vs. Amylyx Pharmaceuticals | Terns Pharmaceuticals vs. Acumen Pharmaceuticals | Terns Pharmaceuticals vs. Inozyme Pharma | Terns Pharmaceuticals vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |